Damora
Redefining care for people with blood disorders
Texas, United States · Founded 2025
- Headquarters
- Texas, Massachusetts
- Employees
- 11–50
- Founded
- 2025
- Business Model
- B2B
- Website
- damoratx.com
About
Damora Therapeutics develops biologic therapies for hematologic disorders, with an initial focus on mutant calreticulin-driven myeloproliferative neoplasms. Its programs target conditions including essential thrombocythemia and myelofibrosis, where it says there is a need for disease-modifying treatments. The company is advancing multiple programs, including DMR-001, with the aim of delivering therapies that offer broad mutation coverage and convenient administration.
Summary
Damora is a Biotech company based in Texas, United States, founded in 2025.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/damora"><img src="https://indexed.vc/api/badge/company/damora" alt="Damora on Indexed.vc" width="260" height="76" /></a>